Duodenoscopes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F

The Global Duodenoscopes Market is projected to expand from USD 181.80 Million in 2025 to USD 250.53 Million by 2031, reflecting a CAGR of 5.49%. These specialized lateral-viewing endoscopes are primarily used during Endoscopic Retrograde Cholangiopancreatography to visualize and treat pathologies within the pancreatic and bile ducts. Market growth is largely driven by the rising prevalence of digestive disorders and an aging population that requires minimally invasive interventions. Underscoring this demand, the American Cancer Society projected that an estimated 66,440 individuals in the United States would be diagnosed with pancreatic cancer in 2024, highlighting the necessity for robust diagnostic and therapeutic endoscopic capacities.

However, market expansion is significantly impeded by the persistent risk of bacterial transmission associated with reprocessing reusable devices. The intricate mechanical design of these scopes makes thorough cleaning and disinfection difficult, leading to potential infections and patient safety concerns. This issue has resulted in heightened regulatory scrutiny and operational complexities for healthcare facilities, thereby acting as a critical restraint on the broader adoption of traditional reusable duodenoscopes.

Market Driver

The rising global prevalence of pancreaticobiliary and gastrointestinal disorders serves as the primary catalyst for market growth, creating sustained demand for therapeutic interventions. As the incidence of conditions such as bile duct stones and malignancies increases, the volume of Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures rises, necessitating a consistent supply of high-performance devices. This surge in demand is evident in the financial results of major industry players; for instance, Boston Scientific reported in its '2023 Annual Report' from March 2024 that its Endoscopy segment achieved net sales of $2.482 billion, an 11.7% increase from the prior year. Additionally, the Pancreatic Cancer Action Network noted in a January 2024 article that approximately 51,750 Americans were projected to die from pancreatic cancer in 2024, reinforcing the critical need for effective endoscopic intervention tools.

Concurrently, a rapid shift toward single-use duodenoscopes is restructuring the market landscape to mitigate cross-contamination risks. Reusable devices, due to their complex elevator mechanisms, are difficult to disinfect completely, creating a persistent threat of patient-to-patient bacterial transmission. This safety concern is driving healthcare facilities to adopt sterile, disposable scopes, which eliminate reprocessing requirements and reduce infection liability. This transition is gaining significant commercial traction, as evidenced by Ambu A/S in its 'Annual Report 2023/24' from November 2024, where the company reported organic revenue growth of 19.7% in its Endoscopy Solutions business, attributed to the widening adoption of its single-use technologies. This trend reflects a broader industry move towards disposable platforms to ensure compliance with tightening regulatory infection control standards.

Market Challenge

The persistent risk of bacterial transmission associated with reprocessing reusable devices constitutes a significant restraint on the Global Duodenoscopes Market. The intricate mechanical design of these instruments creates substantial difficulties in cleaning and disinfection, which significantly increases the potential for patient infections. This safety challenge compels healthcare facilities to implement highly rigorous and time-consuming sterilization protocols that reduce procedural throughput and escalate operational costs. Consequently, the heightened scrutiny and liability concerns discourage the widespread uptake of traditional reusable models and hamper overall market growth.

Substantiating this restraint, ECRI ranked insufficient or onerous device cleaning instructions as the second highest health technology hazard in 2024. This classification highlights the industry-wide struggle with reprocessing complex medical instruments, validating the high level of operational burden that restricts the scalability of the reusable duodenoscope segment.

Market Trends

The development of next-generation visualization technologies for biliary imaging is shifting clinical standards by enhancing the visualization of mucosal structures during complex endoscopic procedures. Innovations such as advanced image processing and high-definition contrast modes are increasingly replacing standard white-light imaging, enabling endoscopists to better visualize the papilla and pancreatobiliary anatomy for improved cannulation rates. This technological shift is gaining rapid commercial acceptance as hospitals upgrade their capital equipment to support superior diagnostic capabilities. Highlighting this adoption, Olympus Corporation noted in its 'Consolidated Financial Results for Fiscal 2024' presentation in May 2024 that the sales ratio of the company's advanced EVIS X1 series rose to approximately 30 percent of its total gastrointestinal endoscopy sales in the fourth quarter, signaling a strong market preference for enhanced imaging platforms.

Concurrently, the expansion of specific reimbursement codes for disposable endoscopic procedures is dismantling the financial barriers that historically impeded the uptake of single-use devices. While the clinical shift toward sterile instruments is recognized, the recent implementation of transitional pass-through payments and distinct billing codes has been the decisive factor in making these high-cost consumables economically viable for healthcare providers. This financial enablement is directly correlating with increased utilization rates of disposable duodenoscopes as hospitals leverage these economic frameworks to balance their budgets. Validating this trend, Boston Scientific reported in October 2024 regarding its third-quarter results that its Endoscopy segment achieved double-digit revenue growth for the Exalt Model D single-use duodenoscope, demonstrating how improved reimbursement structures are accelerating the commercial scalability of disposable solutions.

Key Market Players

• Custom Ultrasonics, Inc.
• Fujifilm Holdings Corporation
• Hoya Corporation
• KARL STORZ GmbH & Co. KG
• Olympus Corporation
• PENTAX Medical Company
• Ambu A/S
• Boston Scientific Corporation
• EndoMed Systems
• HOYA Corp.

Report Scope

In this report, the Global Duodenoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Duodenoscopes Market, By Product

• flexible duodenoscopes
• rigid duodenoscopes

Duodenoscopes Market, By Application

• diagnostics
• therapeutics

Duodenoscopes Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Duodenoscopes Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Duodenoscopes Market.

Available Customizations:

Global Duodenoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).